http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 22 Oct 2026 13:32:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Coastal+Financial+Corporation+to+Report+Third+Quarter+2026+Results+and+Host+a+Conference+Call+on+October+29%2C+2026/27221833.html <p>EVERETT, Wash., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Coastal Financial Corporation (Nasdaq: CCB) (the “Company”, &quot;Coastal&quot;, &quot;we&quot;, &quot;our&quot;, or &quot;us&quot;), the holding company for Coastal Community Bank (the “Bank”), through which it operates a community-focused bank segment and an industry leading banking as a service segment (&quot;CCBX&quot;), will report third quarter 2026 financial results pre-market on Thursday, October 29, 2026.</p> <p>In conjunction with the release of its earnings, the Company’s management team will host a conference call at 8:00 a.m. ET (5:00 a.m. PT) to review and discuss the results.</p> <p>A live webcast of the conference http://www.streetinsider.com/Press+Releases/Coastal+Financial+Corporation+to+Report+Third+Quarter+2026+Results+and+Host+a+Conference+Call+on+October+29%2C+2026/27221833.html Thu, 22 Oct 2026 13:32:00 -0400 CCB http://www.streetinsider.com/Globe+Newswire/Coastal+Financial+Corporation+to+Report+Third+Quarter+2026+Results+and+Host+a+Conference+Call+on+October+29%2C+2026/27221833.html <p>EVERETT, Wash., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Coastal Financial Corporation (Nasdaq: CCB) (the “Company”, &quot;Coastal&quot;, &quot;we&quot;, &quot;our&quot;, or &quot;us&quot;), the holding company for Coastal Community Bank (the “Bank”), through which it operates a community-focused bank segment and an industry leading banking as a service segment (&quot;CCBX&quot;), will report third quarter 2026 financial results pre-market on Thursday, October 29, 2026.</p> <p>In conjunction with the release of its earnings, the Company’s management team will host a conference call at 8:00 a.m. ET (5:00 a.m. PT) to review and discuss the results.</p> <p>A live webcast of the conference http://www.streetinsider.com/Globe+Newswire/Coastal+Financial+Corporation+to+Report+Third+Quarter+2026+Results+and+Host+a+Conference+Call+on+October+29%2C+2026/27221833.html Thu, 22 Oct 2026 13:32:00 -0400 CCB http://www.streetinsider.com/Press+Releases/INVESTOR+ACTION+NOTICE%3A+Moore+Law+PLLC+Encourages+Investors+in+Coastal+Financial+Corporation+to+Contact+Law+Firm/27210572.html <div class="xn-content"> <ul type="disc"> <li><b><span value="NASDAQ-NMS:CCB" idsrc="xmltag.org" >Coastal Financial Corporation</span> (NASDAQ: CCB) </b>shareholders should email <a target="_blank" href="mailto:fletcher@fmoorelaw.com" target="_blank" rel="nofollow">fletcher@fmoorelaw.com</a></li> </ul> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Oct. 20, 2026</chron></span> /PRNewswire/ --</p> http://www.streetinsider.com/Press+Releases/INVESTOR+ACTION+NOTICE%3A+Moore+Law+PLLC+Encourages+Investors+in+Coastal+Financial+Corporation+to+Contact+Law+Firm/27210572.html Tue, 20 Oct 2026 16:13:00 -0400 CCB http://www.streetinsider.com/PRNewswire/INVESTOR+ACTION+NOTICE%3A+Moore+Law+PLLC+Encourages+Investors+in+Coastal+Financial+Corporation+to+Contact+Law+Firm/27210572.html <div class="xn-content"> <ul type="disc"> <li><b><span value="NASDAQ-NMS:CCB" idsrc="xmltag.org" >Coastal Financial Corporation</span> (NASDAQ: CCB) </b>shareholders should email <a target="_blank" href="mailto:fletcher@fmoorelaw.com" target="_blank" rel="nofollow">fletcher@fmoorelaw.com</a></li> </ul> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Oct. 20, 2026</chron></span> /PRNewswire/ --</p> http://www.streetinsider.com/PRNewswire/INVESTOR+ACTION+NOTICE%3A+Moore+Law+PLLC+Encourages+Investors+in+Coastal+Financial+Corporation+to+Contact+Law+Firm/27210572.html Tue, 20 Oct 2026 16:13:00 -0400 CCB http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Bank+of+America+Corporation+%28NYSE%3A+BAC%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+and+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3A+G/27207323.html <p align="justify">PHILADELPHIA, Oct. 20, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Bank+of+America+Corporation+%28NYSE%3A+BAC%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+and+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3A+G/27207323.html Tue, 20 Oct 2026 08:40:26 -0400 AARD BAC CCB ERAS http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Bank+of+America+Corporation+%28NYSE%3A+BAC%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+and+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3A+G/27207323.html <p align="justify">PHILADELPHIA, Oct. 20, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Bank+of+America+Corporation+%28NYSE%3A+BAC%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+and+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3A+G/27207323.html Tue, 20 Oct 2026 08:40:26 -0400 AARD BAC CCB ERAS http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Bank+of+America+Corporation+%28NYSE%3A+BAC%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+and+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3A+G/27207323.html <p align="justify">PHILADELPHIA, Oct. 20, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Bank+of+America+Corporation+%28NYSE%3A+BAC%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+and+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3A+G/27207323.html Tue, 20 Oct 2026 08:40:26 -0400 AARD BAC CCB ERAS http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Bank+of+America+Corporation+%28NYSE%3A+BAC%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+and+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3A+G/27207323.html <p align="justify">PHILADELPHIA, Oct. 20, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Bank+of+America+Corporation+%28NYSE%3A+BAC%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+and+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3A+G/27207323.html Tue, 20 Oct 2026 08:40:26 -0400 AARD BAC CCB ERAS http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Bank+of+America+Corporation+%28NYSE%3A+BAC%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+and+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3A+G/27207323.html <p align="justify">PHILADELPHIA, Oct. 20, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Bank+of+America+Corporation+%28NYSE%3A+BAC%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+and+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3A+G/27207323.html Tue, 20 Oct 2026 08:40:26 -0400 AARD BAC CCB ERAS http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Bank+of+America+Corporation+%28NYSE%3A+BAC%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+and+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3A+G/27207323.html <p align="justify">PHILADELPHIA, Oct. 20, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Bank+of+America+Corporation+%28NYSE%3A+BAC%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+and+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3A+G/27207323.html Tue, 20 Oct 2026 08:40:26 -0400 AARD BAC CCB ERAS http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Bank+of+America+Corporation+%28NYSE%3A+BAC%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+and+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3A+G/27207323.html <p align="justify">PHILADELPHIA, Oct. 20, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Bank+of+America+Corporation+%28NYSE%3A+BAC%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+and+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3A+G/27207323.html Tue, 20 Oct 2026 08:40:26 -0400 AARD BAC CCB ERAS http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Bank+of+America+Corporation+%28NYSE%3A+BAC%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+and+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3A+G/27207323.html <p align="justify">PHILADELPHIA, Oct. 20, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Bank+of+America+Corporation+%28NYSE%3A+BAC%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+and+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3A+G/27207323.html Tue, 20 Oct 2026 08:40:26 -0400 AARD BAC CCB ERAS http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html <p align="justify">PHILADELPHIA, Oct. 19, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html Mon, 19 Oct 2026 07:00:00 -0400 AARD CCB HUBG PSIX http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html <p align="justify">PHILADELPHIA, Oct. 19, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html Mon, 19 Oct 2026 07:00:00 -0400 AARD CCB HUBG PSIX http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html <p align="justify">PHILADELPHIA, Oct. 19, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html Mon, 19 Oct 2026 07:00:00 -0400 AARD CCB HUBG PSIX http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html <p align="justify">PHILADELPHIA, Oct. 19, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html Mon, 19 Oct 2026 07:00:00 -0400 AARD CCB HUBG PSIX http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html <p align="justify">PHILADELPHIA, Oct. 19, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html Mon, 19 Oct 2026 07:00:00 -0400 AARD CCB HUBG PSIX http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html <p align="justify">PHILADELPHIA, Oct. 19, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html Mon, 19 Oct 2026 07:00:00 -0400 AARD CCB HUBG PSIX http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html <p align="justify">PHILADELPHIA, Oct. 19, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html Mon, 19 Oct 2026 07:00:00 -0400 AARD CCB HUBG PSIX http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html <p align="justify">PHILADELPHIA, Oct. 19, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html Mon, 19 Oct 2026 07:00:00 -0400 AARD CCB HUBG PSIX http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html <p align="justify">PHILADELPHIA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- <br /></p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html Thu, 15 Oct 2026 08:30:40 -0400 AARD CCB ERAS PSIX http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html <p align="justify">PHILADELPHIA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- <br /></p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html Thu, 15 Oct 2026 08:30:40 -0400 AARD CCB ERAS PSIX http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html <p align="justify">PHILADELPHIA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- <br /></p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html Thu, 15 Oct 2026 08:30:40 -0400 AARD CCB ERAS PSIX http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html <p align="justify">PHILADELPHIA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- <br /></p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html Thu, 15 Oct 2026 08:30:40 -0400 AARD CCB ERAS PSIX http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html <p align="justify">PHILADELPHIA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- <br /></p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html Thu, 15 Oct 2026 08:30:40 -0400 AARD CCB ERAS PSIX